Literature DB >> 22290719

Identification of distinct subgroups of breast cancer patients based on self-reported changes in sleep disturbance.

Christina Van Onselen1, Bruce A Cooper, Kathryn Lee, Laura Dunn, Bradley E Aouizerat, Claudia West, Marylin Dodd, Steven Paul, Christine Miaskowski.   

Abstract

PURPOSE: The purposes of this study were to identify distinct subgroups of patients based on self-reported sleep disturbance prior to through 6 months after breast cancer surgery and evaluate for differences in demographic, clinical, and symptom characteristics among these latent classes.
METHODS: Women (n = 398) who underwent unilateral breast cancer surgery were enrolled prior to surgery. Patients completed measures of functional status, sleep disturbance (i.e., General Sleep Disturbance Scale (GSDS); higher scores indicate higher levels of sleep disturbance), fatigue, attentional fatigue, depressive symptoms, and anxiety prior to surgery and monthly for 6 months.
RESULTS: Three distinct classes of sleep disturbance trajectories were identified using growth mixture modeling. The high sustained class (55.0%) had high and the low sustained class (39.7%) had low GSDS scores prior to surgery that persisted for 6 months. The decreasing class (5.3%) had high GSDS score prior to surgery that decreased over time. Women in the high sustained class were significantly younger, had more comorbidity and poorer function, and were more likely to report hot flashes compared to the low sustained class. More women who underwent mastectomy or breast reconstruction were in the decreasing class. Decreasing and high sustained classes reported higher levels of physical fatigue, attentional fatigue, depressive symptoms, and anxiety compared to the low sustained class.
CONCLUSIONS: A high percentage of women has significant sleep disturbance prior to surgery that persists during subsequent treatments (i.e., radiation therapy and chemotherapy). Clinicians need to perform routine assessments and initiate appropriate interventions to improve sleep prior to and following surgery.

Entities:  

Mesh:

Year:  2012        PMID: 22290719     DOI: 10.1007/s00520-012-1381-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  44 in total

1.  Pretreatment symptom distress in women newly diagnosed with breast cancer.

Authors:  B Cimprich
Journal:  Cancer Nurs       Date:  1999-06       Impact factor: 2.592

2.  Identification of latent classes in patients who are receiving biotherapy based on symptom experience and its effect on functional status and quality of life.

Authors:  Marylin J Dodd; Maria H Cho; Bruce A Cooper; Judy Petersen; Kayee Alice Bank; Kathryn A Lee; Christine Miaskowski
Journal:  Oncol Nurs Forum       Date:  2011-01       Impact factor: 2.172

3.  Treatment-related symptom clusters in breast cancer: a secondary analysis.

Authors:  Hee-Ju Kim; Andrea M Barsevick; Lorraine Tulman; Paul A McDermott
Journal:  J Pain Symptom Manage       Date:  2008-08-20       Impact factor: 3.612

4.  The measurement structure of the Center for Epidemiologic Studies Depression Scale.

Authors:  T J Sheehan; J Fifield; S Reisine; H Tennen
Journal:  J Pers Assess       Date:  1995-06

5.  Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?

Authors:  Julienne E Bower; Patricia A Ganz; Michael R Irwin; Lorna Kwan; Elizabeth C Breen; Steve W Cole
Journal:  J Clin Oncol       Date:  2011-08-08       Impact factor: 44.544

6.  Differences in sleep disturbance and fatigue between patients with breast and prostate cancer at the initiation of radiation therapy.

Authors:  Kristin Garrett; Anand Dhruva; Theresa Koetters; Claudia West; Steven M Paul; Laura B Dunn; Bradley E Aouizerat; Bruce A Cooper; Marylin Dodd; Kathryn Lee; William Wara; Patrick Swift; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2011-03-31       Impact factor: 3.612

7.  Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period.

Authors:  Josée Savard; Julie Villa; Hans Ivers; Sébastien Simard; Charles M Morin
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

8.  The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes.

Authors:  Dorit Pud; Sarah Ben Ami; Bruce A Cooper; Bradley E Aouizerat; Dorit Cohen; Ruth Radiano; Pnina Naveh; Rivka Nikkhou-Abeles; Vered Hagbi; Orly Kachta; Aliza Yaffe; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2007-12-21       Impact factor: 3.612

9.  Sleep quality after initial chemotherapy for breast cancer.

Authors:  Susan L Beck; Ann M Berger; Andrea M Barsevick; Bob Wong; Katie A Stewart; William N Dudley
Journal:  Support Care Cancer       Date:  2009-06-13       Impact factor: 3.603

10.  Complex regional pain syndrome 1--the Swiss cohort study.

Authors:  Florian Brunner; Lucas M Bachmann; Ulrich Weber; Alfons G H Kessels; Roberto S G M Perez; Johan Marinus; Rudolf Kissling
Journal:  BMC Musculoskelet Disord       Date:  2008-06-23       Impact factor: 2.362

View more
  24 in total

1.  Identification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptoms.

Authors:  Maria Tejada; Carol Viele; Kord M Kober; Bruce A Cooper; Steven M Paul; Laura B Dunn; Marilyn J Hammer; Fay Wright; Yvette P Conley; Jon D Levine; Christine Miaskowski
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

2.  Associations between cytokine gene variations and self-reported sleep disturbance in women following breast cancer surgery.

Authors:  Emely Alfaro; Anand Dhruva; Dale J Langford; Theresa Koetters; John D Merriman; Claudia West; Laura B Dunn; Steven M Paul; Bruce Cooper; Janine Cataldo; Deborah Hamolsky; Charles Elboim; Kord Kober; Bradley E Aouizerat; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2013-09-05       Impact factor: 2.398

3.  Differences in morning and evening fatigue in oncology patients and their family caregivers.

Authors:  Anand Dhruva; Bradley E Aouizerat; Bruce Cooper; Steven M Paul; Marylin Dodd; Claudia West; William Wara; Kathryn Lee; Laura B Dunn; Dale J Langford; John D Merriman; Christina Baggott; Janine Cataldo; Christine Ritchie; Kord Kober; Heather Leutwyler; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2013-09-05       Impact factor: 2.398

4.  Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery.

Authors:  Geraldine Leung; Christina Baggott; Claudia West; Charles Elboim; Steven M Paul; Bruce A Cooper; Gary Abrams; Anand Dhruva; Brian L Schmidt; Kord Kober; John D Merriman; Heather Leutwyler; John Neuhaus; Dale Langford; Betty J Smoot; Bradley E Aouizerat; Christine Miaskowski
Journal:  Lymphat Res Biol       Date:  2014-02-06       Impact factor: 2.589

5.  Predictors and Trajectories of Morning Fatigue Are Distinct From Evening Fatigue.

Authors:  Fay Wright; Gail D'Eramo Melkus; Marilyn Hammer; Brian L Schmidt; M Tish Knobf; Steven M Paul; Frances Cartwright; Judy Mastick; Bruce A Cooper; Lee-May Chen; Michelle Melisko; Jon D Levine; Kord Kober; Bradley E Aouizerat; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2015-03-28       Impact factor: 3.612

6.  Factors that shape preference for acupuncture or cognitive behavioral therapy for the treatment of insomnia in cancer patients.

Authors:  Sheila N Garland; Whitney Eriksen; Sarah Song; Joshua Dearing; Frances K Barg; Philip Gehrman; Jun J Mao
Journal:  Support Care Cancer       Date:  2018-02-08       Impact factor: 3.603

7.  Efficacy, feasibility, and acceptability of a novel technology-based intervention to support physical activity in cancer survivors.

Authors:  Nancy M Gell; Kristin W Grover; Morgan Humble; Michelle Sexton; Kim Dittus
Journal:  Support Care Cancer       Date:  2016-12-13       Impact factor: 3.603

8.  Modifiable and non-modifiable characteristics associated with sleep disturbance in oncology outpatients during chemotherapy.

Authors:  Sueann Mark; Janine Cataldo; Anand Dhruva; Steven M Paul; Lee-May Chen; Marilyn J Hammer; Jon D Levine; Fay Wright; Michelle Melisko; Kathryn Lee; Yvette P Conley; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2017-03-09       Impact factor: 3.603

9.  Sleep disturbance and cancer-related fatigue symptom cluster in breast cancer patients undergoing chemotherapy.

Authors:  Rina S Fox; Sonia Ancoli-Israel; Scott C Roesch; Erin L Merz; Sarah D Mills; Kristen J Wells; Georgia Robins Sadler; Vanessa L Malcarne
Journal:  Support Care Cancer       Date:  2019-06-03       Impact factor: 3.603

10.  Symptom Trajectories Are Associated With Co-occurring Symptoms During Chemotherapy for Breast Cancer.

Authors:  Meagan Whisenant; Bob Wong; Sandra A Mitchell; Susan L Beck; Kathi Mooney
Journal:  J Pain Symptom Manage       Date:  2018-11-17       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.